Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Nursing technology leaders at a large health system are reporting time savings of 20.6 minutes per nurse across 12-hour shifts while caring for an average of 4.5 patients each. The secret to their success: automated digital documentation.
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.
About 38% of rads surveyed said they had defended against at least one lawsuit, with such specialists at a higher risk than others in internal medicine.
Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation.
ACR recently made its case in a comment letter sent to Health and Human Services Secretary Robert F. Kennedy Jr., highlighting proposed legislation that could help.
U.S. News & World Report has released its annual ranking of the top U.S. hospitals for cardiology, heart surgery and vascular surgery. Did your facility make the cut this year?
By viewing large-language AI models through the lens of harm-reduction thinking, healthcare adopters can cultivate a responsible, ethical and optimal integration of the technology.
Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Nursing technology leaders at a large health system are reporting time savings of 20.6 minutes per nurse across 12-hour shifts while caring for an average of 4.5 patients each. The secret to their success: automated digital documentation.
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
